These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10872589)
1. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. Fukuda K; Guo L; Ohashi N; Yoshikawa M; Yamazoe Y J Chromatogr B Biomed Sci Appl; 2000 May; 741(2):195-203. PubMed ID: 10872589 [TBL] [Abstract][Full Text] [Related]
2. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553 [TBL] [Abstract][Full Text] [Related]
3. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Guo LQ; Fukuda K; Ohta T; Yamazoe Y Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150 [TBL] [Abstract][Full Text] [Related]
4. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Malhotra S; Bailey DG; Paine MF; Watkins PB Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034 [TBL] [Abstract][Full Text] [Related]
5. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Fuhr U Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737 [TBL] [Abstract][Full Text] [Related]
6. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255 [TBL] [Abstract][Full Text] [Related]
7. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Ho PC; Saville DJ; Coville PF; Wanwimolruk S Pharm Acta Helv; 2000 Apr; 74(4):379-85. PubMed ID: 10812937 [TBL] [Abstract][Full Text] [Related]
8. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Jetter A; Kinzig-Schippers M; Walchner-Bonjean M; Hering U; Bulitta J; Schreiner P; Sörgel F; Fuhr U Clin Pharmacol Ther; 2002 Jan; 71(1):21-9. PubMed ID: 11823754 [TBL] [Abstract][Full Text] [Related]
9. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Lilja JJ; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578 [TBL] [Abstract][Full Text] [Related]
10. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus. Masuda M; Watanabe S; Tanaka M; Tanaka A; Araki H J Clin Pharm Ther; 2018 Feb; 43(1):15-20. PubMed ID: 28749005 [TBL] [Abstract][Full Text] [Related]
11. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect. Kakar SM; Paine MF; Stewart PW; Watkins PB Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411 [TBL] [Abstract][Full Text] [Related]
12. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Bailey DG; Dresser GK; Bend JR Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362 [TBL] [Abstract][Full Text] [Related]
13. Drug interactions with grapefruit juice. Ameer B; Weintraub RA Clin Pharmacokinet; 1997 Aug; 33(2):103-21. PubMed ID: 9260034 [TBL] [Abstract][Full Text] [Related]
14. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Yasui N; Kondo T; Furukori H; Kaneko S; Ohkubo T; Uno T; Osanai T; Sugawara K; Otani K Psychopharmacology (Berl); 2000 Jun; 150(2):185-90. PubMed ID: 10907671 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897 [TBL] [Abstract][Full Text] [Related]
16. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Edwards DJ; Bellevue FH; Woster PM Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132 [TBL] [Abstract][Full Text] [Related]
17. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Kupferschmidt HH; Fattinger KE; Ha HR; Follath F; Krähenbühl S Br J Clin Pharmacol; 1998 Apr; 45(4):355-9. PubMed ID: 9578182 [TBL] [Abstract][Full Text] [Related]
18. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Fukuda K; Ohta T; Oshima Y; Ohashi N; Yoshikawa M; Yamazoe Y Pharmacogenetics; 1997 Oct; 7(5):391-6. PubMed ID: 9352575 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Guo LQ; Yamazoe Y Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198 [TBL] [Abstract][Full Text] [Related]
20. The effects of grapefruit juice on the pharmacokinetics of erythromycin. Kanazawa S; Ohkubo T; Sugawara K Eur J Clin Pharmacol; 2001; 56(11):799-803. PubMed ID: 11294369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]